Semliki Forest virus-derived virus-like particles: Characterization of their production and transduction pathways

Journal of General Virology

Volumn 86, Issue 11, 2005, Pages 3129-3136

  Diatta, A ^a   Piver, E ^a   Collin, C ^a   Vaudin, P ^a   Pages J C ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERNAL RIBOSOME ENTRY SITE; MEMBRANE BINDING; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; NONHUMAN; PALMITOYLATION; PRIORITY JOURNAL; REPLICON; RISK REDUCTION; SEMLIKI FOREST ALPHAVIRUS; SEQUENCE HOMOLOGY; TARGET CELL; TRANSGENE; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS ENVELOPE; VIRUS PARTICLE; VIRUS RECOMBINATION; VIRUS REPLICATION;

GENETIC VECTORS; HELA CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; REPLICON; SEMLIKI FOREST VIRUS; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

RABBIT FIBROMA VIRUS; SEMLIKI FOREST VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 27644435737     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81103-0     Document Type: Article

References (42)

1. Abe, A., Miyanohara, A. & Friedmann, T. (1998). Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein. J Virol 72, 6159-6163.
2. Ahola, T., Kujala, P., Tuittila, M., Blom, T., Laakkonen, P., Hinkkanen, A. & Auvinen, P. (2000). Effects of palmitoylation of replicase protein nsP1 on alphavirus infection. J Virol 74, 6725-6733.
3. Berglund, P., Smerdou, C., Fleeton, M. N., Tubulekas, I. & Liljestrom, P. (1998). Enhancing immune responses using suicidal DNA vaccines. Nat Biotechnol 16, 562-565.
4. Bhattacharya, J., Peters, P. J. & Clapham, P. R. (2004). Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles. J Virol 78, 5500-5506.
5. Bijlmakers, M. J. & Marsh, M. (2003). The on-off story of protein palmitoylation. Trends Cell Biol 13, 32-42.
6. Choi, K., Kim, J. H., Li, X., Paek, K. Y., Ha, S. H., Ryu, S. H., Wimmer, E. & Jang, S. K. (2004). Identification of cellular proteins enhancing activities of internal ribosomal entry sites by competition with oligodeoxynucleotides. Nucleic Acids Res 32, 1308-1317.
7. Dorange, F., Piver, E., Bru, T., Collin, C., Roingeard, P. & Pages, J. C. (2004). Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors. J Gene Med 6, 1014-1022.
8. Ehrengruber, M. U. (2002). Alphaviral gene transfer in neurobiology. Brain Res Bull 59, 13-22.
9. Everts, B. & van der Poel, H. G. (2005). Replication-selective oncolytic viruses in the treatment of cancer. Cancer Gene Ther 12, 141-161.
10. Fielding, A. K. (2005). Measles as a potential oncolytic virus. Rev Med Virol 15, 135-142.
11. Fischer, R., Kohler, K., Fotin-Mleczek, M. & Brock, R. (2004). A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J Biol Chem 279, 12625-12635.
12. Holm, K., Weclewicz, K., Hewson, R. & Suomalainen, M. (2003). Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100. J Virol 77, 4805-4817.
13. Kaariainen, L. & Ahola, T. (2002). Functions of alphavirus nonstructural proteins in RNA replication. Prog Nucleic Acid Res Mol Biol 71, 187-222.
14. Kujala, P., Ikaheimonen, A., Ehsani, N., Vihinen, H., Auvinen, P. & Kaariainen, L. (2001). Biogenesis of the Semliki Forest virus RNA replication complex. J Virol 75, 3873-3884.
15. Laakkonen, P., Ahola, T. & Kaariainen, L. (1996). The effects of palmitoylation on membrane association of Semliki Forest virus RNA capping enzyme. J Biol Chem 271, 28567-28571.
16. Larin, S. S., Georgiev, G. P. & Kiselev, S. L. (2004). Gene transfer approaches in cancer immunotherapy. Gene Ther 11, S18-S25.
17. Lebedeva, I., Fujita, K., Nihrane, A. & Silver, J. (1997). Infectious particles derived from Semliki Forest virus vectors encoding murine leukemia virus envelopes. J Virol 71, 7061-7067.
18. Lefrancois, L. & Lyles, D. S. (1982). The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. II. Monoclonal antibodies of nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes. Virology 121, 168-174.
19. Leitner, W. W., Ying, H., Driver, D. A., Dubensky, T. W. & Restifo, N. P. (2000). Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Res 60, 51-55.
20. Leitner, W. W., Hwang, L. N., deVeer, M. J., Zhou, A., Silverman, R. H., Williams, B. R., Dubensky, T. W., Ying, H. & Restifo, N. P. (2003). Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med 9, 33-39.
21. Li, M., Yang, C., Tong, S., Weidmann, A. & Compans, R. W. (2002). Palmitoylation of the murine leukemia virus envelope protein is critical for lipid raft association and surface expression. J Virol 76, 11845-11852.
22. Lundstrom, K. (2001). Alphavirus vectors for gene therapy applications. Curr Gene Ther 1, 19-29.
23. Lundstrom, K. (2002). Alphavirus-based vaccines. Curr Opin Mol Ther 4, 28-34.
24. Lundstrom, K., Ziltener, P., Hermann, D., Schweitzer, C., Richards, J. G. & Jenck, F. (2001). Improved Semliki Forest virus vectors for receptor research and gene therapy. J Recept Signal Transduct Res 21, 55-70.
25. Lundstrom, K., Abenavoli, A., Malgaroli, A. & Ehrengruber, M. U. (2003). Novel Semliki Forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-term enhancement of transgene expression. Mol Ther 7, 202-209.
26. Mizuguchi, H., Xu, Z., Ishii-Watabe, A., Uchida, E. & Hayakawa, T. (2000). IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 1, 376-382.
27. Morita, E. & Sundquist, W. I. (2004). Retrovirus budding. Annu Rev Cell Dev Biol 20, 395-425.
28. Perri, S., Driver, D. A., Gardner, J. P., Sherrill, S., Belli, B. A., Dubensky, T. W., Jr & Polo, J. M. (2000). Replicon vectors derived from Sindbis virus and Semliki Forest virus that establish persistent replication in host cells. J Virol 74, 9802-9807.
29. Rheme, C., Ehrengruber, M. U. & Grandgirard, D. (2005). Alphaviral cytotoxicity and its implication in vector development. Exp Physiol 90, 45-52.
30. Rolls, M. M., Webster, P., Balba, N. H. & Rose, J. K. (1994). Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell 79, 497-506.
31. Rolls, M. M., Haglund, K. & Rose, J. K. (1996). Expression of additional genes in a vector derived from a minimal RNA virus. Virology 218, 406-411.
32. Salonen, A., Vasiljeva, L., Merits, A., Magden, J., Jokitalo, E. & Kaariainen, L. (2003). Properly folded nonstructural polyprotein directs the Semliki Forest virus replication complex to the endosomal compartment. J Virol 77, 1691-1702.
33. Sandrin, V., Russell, S. J. & Cosset, F. L. (2003). Targeting retroviral and lentiviral vectors. Curr Top Microbiol Immunol 281, 137-178.
34. Smerdou, C. & Liljestrom, P. (1999). Two-helper RNA system for production of recombinant Semliki Forest virus particles. J Virol 73, 1092-1098.
35. Smyth, J. W., Fleeton, M. N., Sheehan, B. J. & Atkins, G. J. (2005). Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector. Gene Ther 12, 147-159.
36. Suomalainen, M. (2002). Lipid rafts and assembly of enveloped viruses. Traffic 3, 705-709.
37. Tseng, J. C., Hurtado, A., Yee, H., Levin, B., Boivin, C., Benet, M., Blank, S. V., Pellicer, A. & Meruelo, D. (2004a). Using sindbis viral vectors for specific detection and suppression of advanced ovarian cancer in animal models. Cancer Res 64, 6684-6692.
38. Tseng, J. C., Levin, B., Hurtado, A. & 8 other authors (2004b). Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol 22, 70-77.
39. Vasilakis, N., Falvey, D., Gangolli, S. S., Coleman, J., Kowalski, J., Udem, S. A., Zamb, T. J. & Kovacs, G. R. (2003). Transfection-independent production of alphavirus replicon particles based on poxvirus expression vectors. Nat Biotechnol 21, 932-935.
40. Whitt, M. A. & Rose, J. K. (1991). Fatty acid acylation is not required for membrane fusion activity or glycoprotein assembly into VSV virions. Virology 185, 875-878.
41. Willems, W. R., Kaluza, G., Boschek, C. B., Bauer, H., Hager, H., Schutz, H. J. & Feistner, H. (1979). Semliki Forest virus: cause of a fatal case of human encephalitis. Science 203, 1127-1129.
42. Yao, Y., Ghosh, K., Epand, R. F., Epand, R. M. & Ghosh, H. P. (2003). Membrane fusion activity of vesicular stomatitis virus glycoprotein G is induced by low pH but not by heat or denaturant. Virology 310, 319-332.